PKC η Pseudo-substrate inhibitor: sc-3096

The PKC η Pseudo-substrate inhibitor is a valuable tool in contemporary molecular research, offering insights into the complex regulatory mechanisms governed by protein kinase C eta (PKC η) isoform within cellular signaling networks. This inhibitor, designed to mimic the substrate-binding region of PKC η, competes with endogenous substrates for binding to the enzyme′s catalytic domain, effectively blocking its activity. Through its mechanism of action, the PKC η Pseudo-substrate inhibitor enables researchers to selectively modulate PKC η-mediated signaling pathways, thereby elucidating its role in various cellular processes such as cell proliferation, differentiation, and apoptosis. Widely utilized in biochemical and cell biology studies, this inhibitor has contributed significantly to advancing our understanding of PKC η signaling and its implications in diverse physiological and pathological conditions. Additionally, research employing this inhibitor has facilitated the identification of novel PKC η substrates and regulatory mechanisms, shedding light on the complex interplay between PKC η and other signaling molecules. Continued exploration utilizing the PKC η Pseudo-substrate inhibitor promises to uncover further insights into the functional significance of PKC η in cellular physiology and pathology.